Inventor · disambiguated record
Glen Martyn
Also filed as: MARTYN GLEN · MARTYN GLEN P · MARTYN GLEN PATRICK
4 granted patents·19 pending applications·76 citations·filing 1997–2021
77Inventor score
Files withIMMODULON THERAPEUTICS LTD5INNOVATA LTD2LUCKING SAMUEL W2MALLINCKRODT PHARMA IP TRADING D A C2MARTYN GLEN PATRICK2
Top patents by PatentIndex Score
23 records- 0187US8846105B2Dry powder fibrin sealantKOOPMAN JACOB·Filed 2011·Granted Sep 30, 2014·27 cites·15 claims
- 0286US9717821B2Formulations for wound therapySCHUTTE ELIANE·Filed 2012·Granted Aug 1, 2017·23 cites·19 claims
- 0362US6194001B1Tablet dosage form of clavulanic acid and amoxycillin comprising a trehalose excipientQUADRANT HOLDINGS CAMBRIDGE·Filed 1997·Granted Feb 27, 2001·26 cites·26 claims
- 0462US2008112896A1Therapeutic Compositions for Pulmonary DeliveryMARTYN GLEN P·Filed 2007·Application pending·0 cites
- 0552US2008190424A1Unit dose dry powder inhalerLUCKING SAMUEL W·Filed 2008·Application pending·0 cites
- 0650US2023050258A1Immunotherapeutic treatment of cancerIMMODULON THERAPEUTICS LTD·Filed 2020·Application pending·0 cites
- 0750US2016015792A1Powder formulation comprising thrombin and fibrinogenPROFIBRIX BV·Filed 2014·Application pending·0 cites
- 0849US2019269764A1Powder formulationMALLINCKRODT PHARMA IP TRADING D A C·Filed 2019·Application pending·0 cites
- 0948US2005084537A1Sustained-release compositionsFiled 2002·Application pending·0 cites
- 1047US2024216443A1A mycobacterium for use in cancer therapyIMMODULON THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 1147US2009004275A1Composition for Delivery of an Active AgentQUADRANT DRUG DELIVERY LTD·Filed 2005·Application pending·0 cites
- 1247US2003133879A1Therapeutic composition for pulmonary deliveryFiled 2001·Application pending·0 cites
- 1347US2011120464A1InhalersINNOVATA BIOMED LTD·Filed 2009·Application pending·0 cites
- 1447US2023405114A1Mycobacterial immunotherapy for treating cancerIMMODULON THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 1544US2023084300A1Prevention and treatment of infections including those caused by coronavirusIMMODULON THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 1642US2012132204A1Unit dose dry powder inhalerLUCKING SAMUEL W·Filed 2012·Application pending·0 cites
- 1741US2017304483A1Formulations for wound therapyMALLINCKRODT PHARMA IP TRADING D A C·Filed 2017·Application pending·0 cites
- 1840US2021299187A1Cancer therapyIMMODULON THERAPEUTICS LTD·Filed 2019·Application pending·0 cites
- 1937US2015328159A1CompositionINNOVATA LTD·Filed 2015·Application pending·0 cites
- 2035US2010316724A1CompositionINNOVATA LTD·Filed 2010·Application pending·0 cites
- 2132US2013004542A1CompositionMARTYN GLEN·Filed 2010·Application pending·0 cites
- 2228US2013171294A1Nutritional CompositionsMARTYN GLEN PATRICK·Filed 2011·Application pending·0 cites
- 2327US9119897B2Dry powder fibrin sealantMARTYN GLEN PATRICK·Filed 2010·Granted Sep 1, 2015·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when Glen Martyn files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →